Skip to main content
. 2022 Oct 17;12(10):1503. doi: 10.3390/biom12101503

Figure 2.

Figure 2

Multimodality approaches to diagnose and monitor pancreatic ductal adenocarcinoma (PDAC). Although various methods have been developed, no biomarker or PDAC diagnosis using only one method has been identified. The current situation is to increase the sensitivity and specificity by combining multiple methods. ctDNA, Circulating tumor DNA; UC, uncharacterized.